SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001116502-10-000292
Filing Date
2010-04-09
Accepted
2010-04-09 13:15:59
Documents
3
Period of Report
2010-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 slx_8k.htm 8-K 25307
2 PRESS RELEASE slx_ex991.htm EX-99.1 17755
3 stellarlogo.jpg GRAPHIC 11772
  Complete submission text file 0001116502-10-000292.txt   61069
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 10741955
SIC: 2834 Pharmaceutical Preparations